Is a controlled trial of long-term oral anticoagulants in patients with stroke and non-rheumatic atrial fibrillation worthwhile?

Is a controlled trial of long-term oral anticoagulants in patients with stroke and non-rheumatic atrial fibrillation worthwhile?

A controlled randomised trial large enough to assess the value of anticoagulating stroke patients in atrial fibrillation would be difficult to conduct in the UK and the results would be applicable to only a small proportion of stroke patients. It would be more worthwhile to organise a trial that als...

Descripció completa

Dades bibliogràfiques
Autors principals:	Sandercock, P, Warlow, C, Bamford, J, Peto, R, Starkey, I
Format:	Journal article
Idioma:	English
Publicat:	1986

Ítems similars

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
per: Turpie AGG
Publicat: (2014-03-01)

A new era of anticoagulant therapy in the prevention of stroke in non-rheumatic atrial fibrillation
per: Andrei Viktorovich Fonyakin, et al.
Publicat: (2012-09-01)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
per: Paula Tiili, et al.
Publicat: (2021-01-01)

Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation
per: Tommaso Sacquegna, et al.
Publicat: (2015-12-01)

Prevalence of oral anticoagulation in atrial fibrillation
per: Eduardo Bartholomay, et al.
Publicat: (2014-09-01)

Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke
per: Jin-Yi Hsu, et al.
Publicat: (2022-07-01)

Choice of Oral Anticoagulant: Outcomes in Atrial Fibrillation Patients Post-Stroke Despite Direct Oral Anticoagulant Use
per: Eric Duong, BSc, MSc, PharmD, et al.
Publicat: (2023-08-01)

Mitral valve repair in rheumatics: Is it still worthwhile?
per: Manuel J. Antunes
Publicat: (2017-04-01)

PHARMACODYNAMICS OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ACUTE PERIOD OF ISCHEMIC STROKE
per: V. I. Petrov, et al.
Publicat: (2021-01-01)

Oral anticoagulant use for stroke prevention in atrial fibrillation patients with difficult scenarios
per: Ting-Yung Chang, et al.
Publicat: (2018-09-01)

Non-vitamin K oral anticoagulants (NOACs) in patients with stroke and atrial fibrillation
per: Jovanović Dejana R.
Publicat: (2020-01-01)

Burden of oral anticoagulation in embolic stroke of undetermined source without atrial fibrillation
per: Klaus K. Witte, et al.
Publicat: (2021-03-01)

Satisfaction with oral anticoagulants in patients with atrial fibrillation
per: Suárez Fernández C, et al.
Publicat: (2018-02-01)

Medium-term and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation
per: Giuseppe Armentaro, et al.
Publicat: (2023-07-01)

Do all patients with atrial fibrillation need long-term anticoagulation?
per: Munish Sharma, et al.
Publicat: (2017-07-01)

Long‐Term Medication Adherence Trajectories to Direct Oral Anticoagulants and Clinical Outcomes in Patients With Atrial Fibrillation
per: Jaejin An, et al.
Publicat: (2021-11-01)

Atrial fibrillation, electroconvulsive therapy, stroke risk, and anticoagulation
per: Meera Kapadia, et al.
Publicat: (2023-11-01)

Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey.
per: Holt, T, et al.
Publicat: (2012)

EFFICACY AND SAFETY OF THE NOVEL ORAL ANTICOAGULANTS FOR PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN ATRIAL FIBRILLATION
per: S. K. Zyryanov, et al.
Publicat: (2017-07-01)

Preventing stroke in atrial fibrillation patients &ndash; clinical utility of oral anticoagulants
per: Jhawar MB, et al.
Publicat: (2012-04-01)

Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey
per: Deirdre A. Lane, et al.
Publicat: (2018-07-01)

Stroke prevention within primary care: management of atrial fibrillation using oral anticoagulation
per: Paulo Andrade Lotufo

Stroke Incidence and Death in Atrial Fibrillation Patients Newly Treated with Direct Oral Anticoagulants
per: Gabet A, et al.
Publicat: (2021-02-01)

Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies
per: Amin A
Publicat: (2013-01-01)

Mood disorders in long-term survivors of stroke: associations with brain lesion location and volume.
per: Sharpe, M, et al.
Publicat: (1990)

Oral anticoagulant therapy for older patients with atrial fibrillation
per: Mario Bo, et al.
Publicat: (2017-09-01)

Oral Anticoagulants in Patients with Atrial Fibrillation and Active Cancer
per: Li-Ying Yu, et al.
Publicat: (2022-06-01)

The temporal context of oral anticoagulation outcome in atrial fibrillation
per: Anke C. Fender, et al.
Publicat: (2022-06-01)

Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation
per: Michela Giustozzi, et al.
Publicat: (2019-04-01)

Long-term prognostic impact of anticoagulation on patients with atrial fibrillation undergoing hemodialysis
per: Ruth María Sánchez Soriano, et al.
Publicat: (2018-07-01)

Safety of direct oral anticoagulants in patients with atrial fibrillation and high risk of stroke (review of literature)
per: E. I. Baranova, et al.
Publicat: (2020-02-01)

Risk of gastrointestinal bleeding in Asian patients receiving oral anticoagulants for stroke prevention in atrial fibrillation
per: Alejandro Bimbo Diaz, et al.
Publicat: (2024-08-01)

Frequency of and factors associated with underdosing of direct oral anticoagulants in patients with ischaemic stroke and atrial fibrillation
per: E.M. Bacas, et al.
Publicat: (2024-07-01)

Outcomes of non-vitamin K oral anticoagulants for secondary prevention in ischemic stroke with atrial fibrillation
per: Ki-Woong Nam, et al.
Publicat: (2024-04-01)

Evaluation of the timing of using direct oral anticoagulants after ischemic stroke for patients with atrial fibrillation
per: Hui-Tzu Yu, et al.
Publicat: (2023-03-01)

Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
per: Alfredo Caturano, et al.
Publicat: (2019-09-01)

Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation
per: Celina M. Yong, et al.
Publicat: (2020-05-01)

Oral anticoagulant use and the development of new cerebral microbleeds in cardioembolic stroke patients with atrial fibrillation
per: Toshitaka Umemura, et al.
Publicat: (2020-01-01)

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
per: Xiaoxi Yao, et al.
Publicat: (2016-02-01)

Oral anticoagulant use and the development of new cerebral microbleeds in cardioembolic stroke patients with atrial fibrillation.
per: Toshitaka Umemura, et al.
Publicat: (2020-01-01)